Publication Venue For
Racial Differences in Alzheimer's Disease Specialist Encounters Are Associated with Usage of Molecular Imaging and Dementia Medications: An Enterprise-Wide Analysis Using i2b2.
Relationships between Chronic Pain Stage, Cognition, Temporal Lobe Cortex, and Sociodemographic Variables.
Mid- And Late-Life Leisure-Time Physical Activity and Global Brain Amyloid Burden- And Atherosclerosis Risk in Communities (ARIC)-PET Study.
Ozone and Particulate Matter Exposure and Alzheimer's Disease: A Review of Human and Animal Studies.
Pro-Neurotensin/Neuromedin N and Risk of Cognitive Impairment in a Prospective Study.
Progression of Alzheimer's Disease by Self-Reported Cancer History in the Alzheimer's Disease Neuroimaging Initiative.
Biomarker Localization, Analysis, Visualization, Extraction, and Registration (BLAzER) Methodology for Research and Clinical Brain PET Applications.
Dementia Risk Elevates Brain Activity During Memory Retrieval: A Functional MRI Analysis of Middle Aged and Older Adults.
A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's Disease.
No effects of black tea on cognitive decline among older US men: A prospective cohort study.
Type 1 Diabetes Mellitus and Cognitive Impairments: A Systematic Review.
White Matter Degradation is Associated with Reduced Financial Capacity in Mild Cognitive Impairment and Alzheimer's Disease.
N-Terminal Pro-B-Type Natriuretic Peptide and Risk of Future Cognitive Impairment in the REGARDS Cohort.
Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.
An Update on Type 2 Diabetes Mellitus as a Risk Factor for Dementia.
Noradrenergic sympathetic sprouting and cholinergic reinnervation maintains non-amyloidogenic processing of AβPP.
In vivo and in vitro effects of an apolipoprotein E mimetic peptide on amyloid-β pathology.
Treatment with D3 removes amyloid deposits, reduces inflammation, and improves cognition in aged AβPP/PS1 double transgenic mice.
Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of alzheimer's disease.
Anti-amyloid-β single-chain antibody brain delivery via aav reduces amyloid load but may increase cerebral hemorrhages in an alzheimer's disease mouse model.
Therapeutic potential and anti-amyloidosis mechanisms of tert-butylhydroquinone for Alzheimer's disease.
Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
Lesion-induced hippocampal plasticity in transgenic alzheimer's disease mouse models: Influences of age, genotype, and estrogen.
Vascular endothelial barrier dysfunction mediated by amyloid-β proteins.
Distractibility and Alzheimer disease: The "neglected" phenomenon.